## Abstract The most important features that characterize and differentiate progressive supranuclear palsy (PSP) from other parkinsonian syndromes are postural instability, supranuclear gaze palsy, pseudobulbar palsy, and cognitive disturbances. Although it has been reported that significant autono
Dysfunction of Ib (Autogenic) spinal inhibition in patients with progressive supranuclear palsy
โ Scribed by Dr. Edward J. Fine; Mark Hallett; Irene Litvan; Nancy Tresser; David Katz
- Book ID
- 102949267
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 850 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
We compared the activity of Ib spinal interneurons in five patients with progressive supranuclear palsy (PSP) with six ageโmatched control subjects. Stimulation of the medial gastrocnemius nerve at motor threshold intensity activated Ib afferents that in turn inhibit H reflexes from the soleus muscle. Maximum inhibition occurred at interstimulus intervals of 6 and 8 ms for both control subjects and PSP patients and was significantly greater in the PSP patients. Increased Ib activity of PSP patients may be caused by loss of inhibition of Ib interneurons through degeneration of the medullary reticulospinal pathway. The corticospinal pathways, unopposed by the medullary reticulospinal tract, may excessively activate Ib internurons.
๐ SIMILAR VOLUMES
## Abstract We assessed healthโrelated quality of life (QoL) of patients with progressive supranuclear palsy (PSP), identified the most important QoL issues in patients with this disorder, and assessed the usefulness of existing QoL measures in patients with PSP. Twentyโseven patients in all stages
## Abstract Abnormalities in energy metabolism and oxidative stress accompany many neurodegenerative diseases, including progressive supranuclear palsy (PSP). Previously, we showed decreased activities of a mitochondrial enzyme complex, ฮฑโketoglutarate dehydrogenase complex (KGDHC), and marked incr
## Abstract A dysfunction of multiple neurotransmitter systems is assumed as a neurochemical basis of the akineticโrigid syndrome of progressive supranuclear palsy (PSP). In vitro studies have produced conflicting results on the serotoninergic system in PSP. We, therefore, studied the binding poten